3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
8
Thoracic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
7
Colorectal Neoplasms
6
Neoplasms
4
Neoplasm Metastasis
4
Esophageal Neoplasms
4
Pancreatic Neoplasms
3
Gallbladder Neoplasms
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Bile Duct Neoplasms
2
Prostatic Neoplasms
1
Oesophagogastric Cancer
1
Head and Neck Neoplasms
1
HER2 Positive Esophagogastric Cancer
1
Gastrointestinal Neoplasms
1
GastroEsophageal Cancer
1
Esophageal Squamous Cell Carcinoma
1
Dysgerminoma
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms, Male
1
Interventions
pembrolizumab
29
Cetuximab
11
Nivolumab
10
Fluorouracil
8
Cyclophosphamide
8
Cisplatin
8
Carboplatin
8
fludarabine
7
atezolizumab
7
Blood Specimen Collection
7
cemiplimab
6
Radiotherapy
6
Drug Therapy
6
Immune Checkpoint Inhibitors
5
Gemcitabine
5
Paclitaxel
4
Docetaxel
4
Capecitabine
4
Biopsy
4
spartalizumab
3
avelumab
3
Surveys and Questionnaires
3
Pemetrexed
3
Oncolytic Virotherapy
3
Nicotine
3
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Ipilimumab
3
Interleukin-2
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Lapatinib
×
Gastrointestinal
×
Clear all
NCT01184482
2013-10-31
TYKERB-ITUX 1
Georgetown University
Phase 1
Completed
22 enrolled